GE HealthCare Technologie...

NASDAQ: GEHC · Real-Time Price · USD
73.39
-0.27 (-0.37%)
At close: Aug 15, 2025, 3:59 PM
73.45
0.08%
After-hours: Aug 15, 2025, 05:56 PM EDT

GE HealthCare Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
19.96B 19.8B 19.67B 19.56B 19.52B 19.5B 19.55B 19.28B 19.04B 18.7B 18.34B 17.99B 17.72B 17.58B 17.59B 13B 8.69B 4.35B
Cost of Revenue
11.67B 11.48B 11.47B 11.47B 11.52B 11.56B 11.63B 11.59B 11.5B 11.31B 11.16B 10.88B 10.62B 10.5B 10.41B 7.68B 5.15B 2.57B
Gross Profit
8.3B 8.31B 8.21B 8.09B 8B 7.93B 7.92B 7.7B 7.54B 7.39B 7.18B 7.11B 7.1B 7.08B 7.17B 5.31B 3.55B 1.77B
Operating Income
2.76B 2.71B 2.63B 2.51B 2.45B 2.42B 2.44B 2.52B 2.51B 2.57B 2.52B 2.47B 2.52B 2.6B 2.8B 2.07B 1.42B 708M
Interest Income
11M 5M 5M 12M 13M 13M 26M 19M 17M 17M 4M 10M 16M 18M 20M 14M 4M 2M
Pretax Income
2.8B 2.76B 2.58B 2.36B 2.33B 2.33B 2.36B 2.47B 2.46B 2.52B 2.51B 2.55B 2.6B 2.69B 2.88B 2.12B 1.44B 722M
Net Income
2.24B 2.18B 1.99B 1.68B 1.58B 1.57B 1.57B 1.72B 1.83B 1.9B 1.92B 1.93B 1.94B 2.04B 2.23B 1.67B 1.16B 581M
Selling & General & Admin
4.23B 4.27B 4.27B 4.29B 4.25B 4.26B 4.28B 4.01B 3.93B 3.76B 3.63B 3.66B 3.66B 3.62B 3.56B 2.65B 1.74B 869.5M
Research & Development
1.31B 1.33B 1.31B 1.28B 1.29B 1.26B 1.21B 1.16B 1.1B 1.06B 1.03B 980M 920M 858.5M 816M 591M 391M 195.5M
Other Expenses
-4M -2M -2M -2M -1M -1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
5.54B 5.6B 5.58B 5.57B 5.54B 5.52B 5.49B 5.17B 5.03B 4.82B 4.66B 4.64B 4.58B 4.48B 4.38B 3.24B 2.13B 1.06B
Interest Expense
465M 483M 510M 530M 538M 544M 542M 471M 335M 220M 90M 36M 34M 12M 6M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.2B 17.08B 17.05B 17.05B 17.06B 17.08B 17.12B 16.76B 16.53B 16.13B 15.82B 15.52B 15.2B 14.97B 14.76B 10.9B 7.24B 3.62B
Income Tax Expense
481M 511M 531M 628M 710M 704M 743M 701M 580M 596M 564M 592M 623M 600.5M 600M 421M 261M 130.5M
Shares Outstanding (Basic)
457M 457M 457M 457M 457M 456M 455M 455M 455M 454M 453.93M 454M 454M 453.93M 454.71M 454.71M 454.71M 454.71M
Shares Outstanding (Diluted)
458M 459M 459M 459M 459M 459M 458M 458M 458M 457M 453.93M 454.71M 454.71M 454.71M 454.71M 454.71M 454.71M 454.71M
EPS (Basic)
4.90 4.78 4.37 3.68 3.47 3.45 3.05 3.38 3.63 3.78 4.22 4.27 4.31 4.52 4.93 3.66 2.56 1.28
EPS (Diluted)
4.88 4.75 4.33 3.64 3.44 3.42 3.02 3.36 3.61 3.77 4.22 4.27 4.31 4.52 4.93 3.66 2.56 1.28
EBITDA
3.83B 3.81B 3.67B 3.49B 3.48B 3.47B 3.51B 3.55B 3.39B 3.36B 3.22B 3.2B 3.24B 3.29B 3.46B 2.54B 1.73B 866M
EBIT
3.26B 3.25B 3.09B 2.9B 2.89B 2.87B 2.9B 2.93B 2.76B 2.73B 2.58B 2.57B 2.61B 2.66B 2.83B 2.07B 1.42B 708M
Depreciation & Amortization
567M 568M 580M 584M 594M 601M 610M 623M 630M 631M 633M 630M 625M 626M 625M 471M 316M 158M